Recombinant Rat Pyroglutamylated RFamide peptide receptor (Qrfpr)

What is the molecular identity of rat Qrfpr?

Rat pyroglutamylated RFamide peptide receptor (Qrfpr) is a class A G-protein-coupled receptor (GPCR) encoded by the Qrfpr gene (Gene ID: 310327). This receptor, also known as GPR103 or orexigenic neuropeptide QRFP receptor, is selectively activated by QRFP peptides that possess the characteristic C-terminal RF-amide motif. In humans, QRFPR is a 431 amino acid protein containing 7 transmembrane domains, with a similar structure conserved across species including rat . The receptor was initially identified as an orphan GPCR from human brain cDNA libraries, before its endogenous ligands were discovered .

What are the primary endogenous ligands for rat Qrfpr?

The primary endogenous ligands for rat Qrfpr are QRFP peptides, particularly the 26-amino acid form (QRFP26 or 26RFa) and the longer 43-amino acid peptide. These peptides feature the characteristic C-terminal RF-amide motif that is critical for receptor recognition and activation. QRFP26 has been identified as a high-affinity ligand for QRFPR, with the 43-amino acid version appearing necessary for full agonistic activity . Recent structural studies have revealed that QRFP26 adopts an extended conformation when bound to the receptor, with no secondary structure elements, allowing its N-terminal and C-terminal regions to interact with distinct domains of the receptor .

What is the tissue distribution pattern of Qrfpr in rats?

In rats and other mammals, Qrfpr shows a distinct expression pattern with predominant expression in:

• Brain (highest expression)

• Heart

• Kidney

• Retina

• Testis

This distribution pattern suggests diverse physiological roles beyond central nervous system functions. The receptor and its ligand precursor mRNA exhibit particularly high expression in brain tissues, indicating important neurological functions .

What is the structural basis for QRFP recognition by Qrfpr?

Recent cryo-electron microscopy studies have revealed the precise structural basis for QRFP recognition by its receptor. The QRFP26-QRFPR-Gq complex structure at 3.19 Å resolution shows that QRFP26 adopts an extended conformation without secondary structure when bound to the receptor . The binding mechanism involves:

• The N-terminal portion of QRFP26 is recognized by the extracellular domain of QRFPR

• The C-terminal portion interacts with the transmembrane domain of the receptor

• The peptide adopts a unique binding mode where Gly3-Tyr15 in 26RFa forms an α-helix, while the C-terminus displays as an extended loop

• The C-terminal heptapeptide of 26RFa resides within the transmembrane binding pocket

This binding mechanism is critical for high-affinity interaction and receptor specificity .

How does the extracellular region of Qrfpr contribute to ligand binding?

The extracellular region of Qrfpr plays a crucial role in ligand recognition and binding:

• The N-terminus of QRFPR (E9-G42) forms a unique assembly with the peptide's N-terminus and the receptor's ECL2 (extracellular loop 2)

• This assembly is distinctive compared to other class A GPCRs, where the N-terminus is often short or lacks visible structural density

• Mutagenesis experiments have demonstrated that disrupting key residues at the N-terminus-ECL2-26RFa interface significantly reduces peptide activity

• This unique assembly mode contributes to the high specificity of the receptor-ligand interaction

What are the key differences in binding mechanisms between QRFPR and other RF-amide peptide receptors?

Structural comparisons with closely related receptors have revealed both conserved and diversified peptide recognition mechanisms:

• Unlike some related receptors, QRFP26 adopts an extended structure rather than a helical conformation when bound to QRFPR

• The RF-amide moiety of QRFP shows similarities in binding to the transmembrane domain compared to other RF-amide peptides

• The phenyl group of phenylalanine in the RF-amide moiety inserts into the helical core of the receptor, making direct contact with W286^6.48, a conserved toggle switch residue in class A GPCRs responsible for peptide-induced receptor activation

• This binding pattern shares similarities with the RY-amide segment in neuropeptide Y, though with distinct receptor-specific interactions

What structural methods have proven most effective for studying Qrfpr?

Several structural methods have been successfully employed to study Qrfpr, with cryo-electron microscopy (cryo-EM) emerging as particularly effective:

• Cryo-EM has been used to determine the structure of the QRFP26-QRFPR-Gq complex at high resolution (3.19 Å)

• To facilitate the expression of the QRFPR-Gq complex, researchers have introduced a cytochrome b562RIL (BRIL) at the N-terminus of the full-length wild-type human QRFPR

• A Gαq chimera (GαsqiN) engineered based on the mini-Gαs scaffold has been successfully used in structure determination of QRFPR-Gq complexes

• The NanoBiT tethering strategy has been employed to stabilize the QRFPR-Gq complex

• Efficient assembly of the 26RFa-QRFPR-Gq-scFv16 complex was achieved by incubating 26RFa with membranes from cells co-expressing the receptors, Gq heterotrimers, and scFv16

What mutagenesis approaches have been effective in analyzing QRFPR function?

Mutagenesis experiments have been crucial in validating the functional importance of specific residues in QRFPR:

• Site-directed mutagenesis targeting residues at the N-terminus-ECL2-26RFa interface has demonstrated their importance for peptide activity

• Mutations affecting the assembly between the receptor's extracellular region and the peptide significantly impact the regulation of QRFPR activity by 26RFa

• Specific mutations like those affecting L193 at the N-terminus-ECL2-26RFa interface caused remarkable declines in peptide activity

What expression systems are optimal for producing functional recombinant rat Qrfpr?

Based on successful structural and functional studies, certain expression systems have proven effective for recombinant QRFPR production:

• Mammalian expression systems have been used for co-expression of QRFPR with G proteins for structural studies

• Cell membrane preparations from these expression systems have been successfully used for complex formation with ligands and G proteins

• For structural studies, modifications such as fusion with cytochrome b562RIL (BRIL) at the N-terminus of the full-length receptor have facilitated expression and analysis

What are the primary physiological roles of QRFPR in rats?

QRFPR mediates several important physiological functions in rats and other mammals:

• Energy metabolism regulation

• Appetite control and feeding behavior

• Potential roles in adipogenesis regulation through autocrine/paracrine mechanisms

• Adrenal gland function, as evidenced by QRFP administration causing aldosterone release

How does QRFPR signaling differ from other related neuropeptide receptors?

QRFPR exhibits unique signaling characteristics compared to other RF-amide peptide receptors:

• QRFPR selectively couples to the Gq protein pathway, as evidenced by structural studies of the QRFP26-QRFPR-Gq complex

• The activation mechanism involves structural changes in the transmembrane domain, with TM7 showing a slightly inward shift toward the core of the helical bundle upon activation

• The activation mechanism appears to involve conserved "micro-switch" motifs including P5.50T3.40F6.44 and N7.49P7.50xxY7.53

• Though part of the RF-amide family of receptors, QRFPR shows distinct ligand specificity and cellular distribution compared to related receptors like neuropeptide FF (NPFF), prolactin-releasing peptide (PrRP), kisspeptin (Kiss1), and gonadotropin-inhibitory hormone (GnIH) receptors

How conserved is QRFPR across different species?

QRFPR shows significant conservation across mammalian species, with orthologs identified in:

This wide conservation across species suggests the fundamental importance of this receptor system in vertebrate physiology.

What are key differences between rat and human QRFPR?

• Species-specific differences may exist in tissue distribution patterns

• Ligand binding affinities may vary between species

• Signaling pathways and physiological responses could have species-specific characteristics

• When translating findings from rat models to human applications, these potential differences should be considered

How can QRFPR be targeted for therapeutic development?

The structural and functional insights into QRFPR provide various opportunities for therapeutic development:

• The detailed binding mode of QRFP26 with QRFPR offers a foundation for rational drug design

• The flexible region in the peptide binding pocket (around Ser23) presents an opportunity for optimizing peptide activity, as demonstrated by substituting Ser23 with bulkier norvaline leading to enhanced peptide analogs

• Targeting QRFPR may be relevant for conditions related to:

  • Metabolic disorders

  • Appetite regulation

  • Energy homeostasis

• Understanding the unique binding mechanisms of QRFPR compared to other RF-amide peptide receptors allows for developing selective compounds that don't cross-react with related receptors

What are effective approaches for measuring QRFPR activation in experimental settings?

Based on published research methodologies, several approaches can be used to measure QRFPR activation:

• Functional assays measuring Gq-mediated signaling responses, such as calcium mobilization

• Bioluminescence resonance energy transfer (BRET) or NanoBiT-based assays for monitoring protein-protein interactions between QRFPR and G proteins

• Cryo-EM analysis of receptor-G protein complexes for structural confirmation of activation states

• Mutagenesis experiments targeting key residues involved in receptor activation, followed by functional readouts

What are the main challenges in expressing and purifying recombinant rat Qrfpr?

Researchers working with recombinant Qrfpr should be aware of several technical challenges:

• As a 7-transmembrane GPCR, Qrfpr presents typical challenges associated with membrane protein expression and purification

• Maintaining proper folding and functional activity during recombinant expression requires careful optimization

• For structural studies, strategies such as fusion with stabilizing domains (e.g., cytochrome b562RIL) have been beneficial

• Complex formation with G proteins and ligands typically requires co-expression systems or efficient reconstitution methods

What quality control measures are essential when working with recombinant Qrfpr?

Quality control for recombinant Qrfpr research should include: